EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration

Eduardo Anitua iD, Roberto Tierno, Gorka Orive, Mohammad Hamdan Alkhraisat

Drug Design, Development and Therapy · 2025-09 · Volume 19 · 8755-8782

DOI: 10.2147/dddt.s546097 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-09. Verfasst von Eduardo Anitua und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, BTI Biotechnology Institute, Vitoria, Alava, Spain. Hauptthemen laut MEDLINE: Biocompatible Materials, Wound Healing, Skin Diseases, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment of dermatological diseases has evolved significantly with the advent of advanced therapeutic strategies involving platelet-rich products. These products are rich in morphogens, growth factors, and proteins that play a crucial role in tissue regeneration and wound healing. Their combination with different biomaterials has been engineered to enhance the biomaterials' safety and performance in the context of tissue healing.

Objective

This narrative review aims to explore the current evidence on the biological mechanisms, efficacy, and clinical applications of these combined therapies. Furthermore, we examine the potential advantages of synergistic effects and the challenges associated with optimizing treatment protocols.

Methods

Relevant literature was retrieved through a structured search strategy implemented across PubMed, Scopus, and Google Scholar databases. Studies included investigated co-administration of platelet-rich products with other agents in topical, injectable, or composite formulations for dermatological conditions with no restriction regarding publication date.

Results

The review summarizes in vitro and in vivo biological effects of various biopolymers and active substances combined with platelet-rich products, highlighting diverse application strategies and their effectiveness across dermatological contexts.

Conclusion

Adding platelet-rich products has shown promising results in enhancing therapeutic outcomes for various dermatological conditions, including chronic wounds, burns, scars, and skin aging. Although promising results have been reported, the need for critical thinking regarding the selection of the biomaterial and the platelet-rich products, standardized methodologies, large-scale randomized controlled trials, and long-term follow-up studies is emphasized to fully establish the clinical benefits of these combined treatments in dermatology. In recent years, there have been major advancements in how skin diseases and injuries are treated. Platelet-rich products are one of the most promising techniques, which are derived from a patient’s blood and carry high concentrations of natural growth and repair factors. They stimulate tissue healing and regeneration and, when combined with advanced biomaterials, presumably enhance both efficacy and safety of skin healing processes. This review gathers current evidence on mechanisms, clinical effectiveness, and dermatological applications of such combination therapies. It highlights their uses in a wide range of disorders—spanning from wounds, burns, and scars to skin aging, autoimmune disorder, and alopecia—and their formulation as creams, injections, or scaffolds. Evidence has shown that the integration of platelet-rich products with biomaterials or bioactive agents may facilitate quicker healing and improve clinical performance in experimental and clinical studies. Nevertheless, the review highlights the need for stronger studies, standardized protocols, and long-term follow-up to confirm their therapeutic value and facilitate their translation into routine dermatological practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biocompatible MaterialsWound HealingSkin DiseasesBlood PlateletsHumansAnimalsRegeneration

Stichwörter der Autor:innen

bioactive moleculesbiopolymerdermatologyplasma rich in growth factorsplatelet-rich plasmaskin regenerationwound healing

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Department of Regenerative Medicine, BTI Biotechnology Institute, Vitoria, Alava, Spain.
  • Department of Regenerative Medicine, University Institute for Regenerative Medicine & Oral Implantology, UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Alava, Spain.

ORCID-Profile: Eduardo Anitua

Zitieren

APA

Anitua, E., Tierno, R., Orive, G., & Alkhraisat, M. H. (2025). Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration. Drug Design, Development and Therapy, Volume 19, 8755-8782. https://doi.org/10.2147/dddt.s546097

Vancouver

Anitua E, Tierno R, Orive G, Alkhraisat MH. Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration. Drug Design, Development and Therapy. 2025;Volume 19:8755-8782. doi:10.2147/dddt.s546097

BibTeX
@article{Anitua2025,
  author = {Anitua, Eduardo and Tierno, Roberto and Orive, Gorka and Alkhraisat, Mohammad Hamdan},
  title = {Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {8755--8782},
  doi = {10.2147/dddt.s546097}
}
Kostenlos starten →